LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis

References

• Shi B, Zhang X, Chao L, et al. Comprehensive analysis of key genes, microRNAs and long noncoding RNAs in hepatocellular carcinoma. FEBS Open Bio. 2018;8(9):1424–1436.
   PubMed Web of Science ®Google Scholar
• Couri T, Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13(2):125–137.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol. 2017;72(8):626–635.
   PubMed Web of Science ®Google Scholar
• Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(15):4115–4127.
   PubMed Web of Science ®Google Scholar
• Haoming M, Bin Z, Liu L, et al. Molecular pattern of lncRNAs in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38:198.
   PubMed Web of Science ®Google Scholar
• Shruti,Verma M, Sumit S, Vipin R, et al. Long noncoding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases. Cell Mol Life Sci. 2019;1:1947–1966
   Google Scholar
• Huang X, Gao Y, Qin J, et al. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214. Am J Physiol Gastrointest Liver Physiol. 2018;314(5):G559–G565.
   PubMed Web of Science ®Google Scholar
• Xiao J, Lv Y, Jin F, et al. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma. Cell Physiol Biochem. 2017;43(5):1926–1938.
   PubMedGoogle Scholar
• Huang K, Fan WS, Fu XY, et al. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer. Eur Rev Med Pharmacol Sci. 2020;24(13):7211.
   PubMed Web of Science ®Google Scholar
• Jiao M, Guo H, Chen Y, et al. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS. Biomed Pharmacother. 2020;128:110323.
   PubMed Web of Science ®Google Scholar
• Liu D, Liu H, Jiang Z, et al. Long noncoding RNA DARS-AS1 promotes tumorigenesis of non-small cell lung cancer via targeting miR-532-3p. [published online ahead of print Jul 17]. Minerva Med. 2019; 10.23736/S0026-4806.19.06198–6.
   Web of Science ®Google Scholar
• Zhu J, Han S. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p. Technol Cancer Res Treat. 2020;19:1533033820971669.
   Web of Science ®Google Scholar
• Case CM, Sackett DL, Danny W, et al. CKAP2 ensures chromosomal stability by maintaining the integrity of microtubule nucleation sites. PLoS ONE. 2013;8:e64575.
   PubMed Web of Science ®Google Scholar
• Wang K, Huang R, Li G, et al. CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in highgrade glioma. Oncol Rep. 2018;40(4):2036–2046.
   PubMed Web of Science ®Google Scholar
• Shuwei,Wang Z, Chen Y, Shuzhen, et al. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells. Biomed Pharmacother. 2018;106:1396–1403.
   PubMed Web of Science ®Google Scholar
• Hoon SS, Chang-Dae B, Youngmi K, et al. CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer. PLoS ONE. 2017;12:e0182107.
   PubMed Web of Science ®Google Scholar
• Qi-Sang G, Yu S, Ke-Qin H, et al. Involvement of FAK-ERK2 signaling pathway in CKAP2-induced proliferation and motility in cervical carcinoma cell lines. Sci Rep. 2017;7:2117.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Ohtsuka M, Okamura D, et al. Cytoskeleton-associated protein 2 is a potential predictive marker for risk of early and extensive recurrence of hepatocellular carcinoma after operative resection. Surgery. 2014;155:114–123.
   PubMed Web of Science ®Google Scholar
• Lerch M, Kenerson H, Theiss A, et al. Rapid tissue processing using a temperature-controlled collection device to preserve tumor biomarkers. Cell Tissue Bank. 2020;21(1):89–97
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhou Z, Huang Z, et al. Histone-fold centromere protein W (CENP-W) is associated with the biological behavior of hepatocellular carcinoma cells. Bioengineered. 2020;11(1):729–742.
   PubMed Web of Science ®Google Scholar
• Wang S, Li P, Jiang G, et al. Long noncoding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020;11(1):718–728.
   PubMed Web of Science ®Google Scholar
• Liang M, Huang G, Liu Z, et al. Elevated levels of hsa_circ_006100 in gastric cancer promote cell growth and metastasis via miR-195/GPRC5A signalling. Cell Prolif. 2019 Sep;52(5):e12661.
   PubMed Web of Science ®Google Scholar
• Lingadahalli S, Jadhao S, Sung YY, et al. Novel lncRNA LINC00844 regulates prostate cancer cell migration and invasion through AR signaling. Mol Cancer Res. 2018 Dec;16(12):1865–1878.
   PubMed Web of Science ®Google Scholar
• Peng L, Sang H, Wei S, et al. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2. Mol Cancer. 2020 Nov 5;19(1):156.
   PubMed Web of Science ®Google Scholar
• Wang H, Jiao H, Jiang Z, et al. Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals. Bioengineered. 2020;11(1):510–521.
   PubMed Web of Science ®Google Scholar
• Cao Y, Shen T, Zhang C, et al. MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway. Eur Rev Med Pharmacol Sci. 2019Oct;23(19):8249–8256. PMID: 31646555.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017 Jul 3;45((W1)):W98–W102.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhou Y, Han F, et al. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis. Theranostics. 2020 Jun 1;10(16):7193–7210.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang Y, Wang X, et al. miR-335-5p suppresses gastric cancer progression by targeting MAPK10. Cancer Cell Int. 2021;21(1):71.
   PubMed Web of Science ®Google Scholar
• Hazini A, Dieringer B, Pryshliak M, et al. miR-375- and miR-1-regulated coxsackievirus b3 has no pancreas and heart toxicity but strong anti-tumor efficiency in colorectal carcinomas [published online ahead of print. Hum Gene Ther. 2021Jan22;32(3–4):216–230. 2021.
   PubMed Web of Science ®Google Scholar
• Mao Y, Chen W, Wu H, et al. Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma. Onco Targets Ther. 2021;13:13479–13490.
   PubMed Web of Science ®Google Scholar
• Zheng W, Tian X, Cai L, et al. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer. Eur Rev Med Pharmacol Sci. 2019;23(23):10443–10452.
   PubMed Web of Science ®Google Scholar
• Dou B, Jiang Z, Chen X, et al. Oncogenic long noncoding RNA DARS-AS1 in childhood acute myeloid leukemia by binding to microRNA-425. Technol Cancer Res Treat. 2020;19:1533033820965580.
   Web of Science ®Google Scholar
• Wang S, Cheng Y, Yang P, et al. Silencing of long noncoding RNA LINC00324 interacts with microRNA-3200-5p to attenuate the tumorigenesis of gastric cancer via regulating BCAT1. Gastroenterol Res Pract. 2020;2020:4159298.
   PubMed Web of Science ®Google Scholar
• Mohammadinejad R, Biagioni A, Arunkumar G, et al. EMT signaling: potential contribution of CRISPR/Cas gene editing. Cell Mol Life Sci. 2020;77(14):2701–2722.
   PubMed Web of Science ®Google Scholar
• Lu H-Y, Chu H-X, Tan Y-X, et al. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo. Life Sci. 2020;244:117343.
   PubMed Web of Science ®Google Scholar
• Sun C-M, Geng J, Yan Y, et al. Overexpression of CKAP4 is associated with poor prognosis in clear cell renal cell carcinoma and functions via cyclin B signaling. J Cancer. 2017;8(19):4018–4026.
   PubMed Web of Science ®Google Scholar
• Shinno N, Kimura H, Sada R, et al. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug. Oncogene. 2018;37(26):3471–3484.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu W, He M, et al. Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma. Onco Targets Ther. 2018;12:359–364.
   PubMed Web of Science ®Google Scholar
• Han-Seong,Koh K, Jae-Soo C, Yong-Bock, et al. Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer. PLoS ONE. 2014;9:e98160.
   PubMed Web of Science ®Google Scholar
• Sun C, Enkhjargal B, Reis C, et al. Osteopontin-Enhanced Autophagy Attenuates Early Brain Injury via FAK-ERK Pathway and Improves Long-Term Outcome after Subarachnoid Hemorrhage in Rats. Cells. 2019;8(9):980.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao L. CKAP2 promotes ovarian cancer proliferation and tumorigenesis through the FAK-ERK pathway. DNA Cell Biol. 2017;36(11):983–990.
   PubMed Web of Science ®Google Scholar
• Siu MKY, Yu-Xin J, Jing-Jing W, et al. Hexokinase 2 regulates ovarian cancer cell migration, invasion and stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 signaling cascades.[J]. Cancers (Basel). 2019;11. 10.3390/cancers11060813. undefined.
   PubMed Web of Science ®Google Scholar
• Chengmei,Enkhjargal S, Budbazar RC, et al. Osteopontin-enhanced autophagy attenuates early brain injury via FAK-ERK pathway and improves long-term outcome after subarachnoid hemorrhage in rats. Cells. 2019;8. undefined.
   Web of Science ®Google Scholar
• Jia Ya-Li, Shi Lei, Zhou Jun-Nian, et al. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology. 2011;54(5):1808–1818.
   PubMed Web of Science ®Google Scholar